-
1 Comment
Genesis Healthcare, Inc is currently in a long term downtrend where the price is trading 21.6% below its 200 day moving average.
From a valuation standpoint, the stock is 100.0% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 0.0.
Genesis Healthcare, Inc's total revenue sank by 19.1% to $919M since the same quarter in the previous year.
Its net income has increased by 32.7% to $-8M since the same quarter in the previous year.
Finally, its free cash flow grew by 154.4% to $21M since the same quarter in the previous year.
Based on the above factors, Genesis Healthcare, Inc gets an overall score of 3/5.
Exchange | F |
---|---|
CurrencyCode | EUR |
ISIN | None |
Sector | |
Industry |
Market Cap | 40M |
---|---|
PE Ratio | None |
Target Price | 0.43 |
Dividend Yield | 0.0% |
Beta | -0.45 |
Genesis Healthcare, Inc., together with its subsidiaries, owns and operates skilled nursing facilities and assisted/senior living facilities in the United States. The company operates through three segments: Inpatient Services; Rehabilitation Therapy Services; and Other Services. It also provides a range of rehabilitation therapy services, including speech-language pathology, physical therapy, occupational therapy, and respiratory therapy. In addition, the company offers other specialty medical services, such as physician, staffing, and other healthcare related services. As of December 31, 2020, it provided inpatient services through a network of approximately 341 skilled nursing facilities and assisted/senior living communities in 24 states; and supplied rehabilitation and respiratory therapy to approximately 1,400 healthcare locations in 42 states, the District of Columbia and China. The company was formerly known as FC-GEN Operations Investment, LLC and changed its name to Genesis HealthCare, Inc. in February 2015. Genesis HealthCare, Inc. was founded in 2003 and is headquartered in Kennett Square, Pennsylvania.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for SH11.F using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025